Michael Forbes, CEO of Adastra, stated in his initial press release: “Hurt reduction can be a critically essential and mainstream subject, and we're being with the forefront of drug regulations through the board.”The corporate didn’t involve that element in its initial push release, which said Adastra is now licensed to deal with around 250 g… Read More